• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

雷洛昔芬与甲氨蝶呤在人乳腺癌细胞中的序列依赖性和时间依赖性拮抗作用。

Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.

作者信息

De Soto Joseph A, Bowen Donnell, Davis Jillian H, Southerland William M, Hawkins Morris

机构信息

Department of Pharmacology, Howard University College of Medicine, Washington, DC 20059, USA.

出版信息

Anticancer Res. 2002 Mar-Apr;22(2A):1007-9.

PMID:12014617
Abstract

The selective estrogen receptor modulator (SERM) and an agent for the prevention of osteoporosis in postmenopausal women, raloxifene (Ral), decreased high-dose methotrexate (MTX) cytotoxicity in MCF-7 breast cancer cells. When Ral is given at least 24 hours prior to MTX, the resultant interaction is antagonistic. However, when breast cancer cells are exposed to Ral 24 hours after MTX, the interaction between Ral and MTX is not antagonistic. The proliferation of cells exposed to 10 microM Ral and 10 microM MTX alone or in combination with Ral 24 hours prior to MTX was in had the following order: MTX > Ral 24 hours prior to MTX > Ral. MTX administration 24 hours prior to Ral had the following inhibitory effects on the growth of cells: MTX 24 hours prior to Ral > or = MTX > Ral 24 hours prior to MTX > Ral > control (no drug exposure). To determine if the antagonistic interaction between Ral and MTX was a function of sequence and time, cells were exposed to Ral 24 hours and 36 hours prior to MTX exposure. The percentages of control rates were 43.48 +/- 3.90% and 54.43 +/- 2.93%, respectively, from a 24 hours and 36 hours exposure of Ral prior to MTX. The growth rates after 24 h and 36 h exposures to MTX alone were 30.30 +/- 0.61% and 33.11 +/- 2.27% of control rates, respectively. These studies suggest that: (a) the interactions between Ral and MTX are sequence-dependent; (b) Ral antagonizes the effect of MTX when Ral administration precedes MTX; and (c) Ral antagonism to MTX is a function of time.

摘要

选择性雌激素受体调节剂(SERM)雷洛昔芬(Ral)是一种用于预防绝经后女性骨质疏松症的药物,它可降低MCF-7乳腺癌细胞中高剂量甲氨蝶呤(MTX)的细胞毒性。当在MTX给药前至少24小时给予Ral时,产生的相互作用是拮抗的。然而,当乳腺癌细胞在MTX给药24小时后暴露于Ral时,Ral与MTX之间的相互作用不是拮抗的。单独暴露于10μM Ral和10μM MTX或在MTX给药前24小时与Ral联合暴露的细胞增殖情况如下:MTX>MTX给药前24小时的Ral>Ral。在Ral给药前24小时给予MTX对细胞生长有以下抑制作用:Ral给药前24小时的MTX≥MTX>MTX给药前24小时的Ral>Ral>对照(无药物暴露)。为了确定Ral与MTX之间的拮抗相互作用是否是顺序和时间的函数,在MTX暴露前24小时和36小时将细胞暴露于Ral。在MTX暴露前分别24小时和36小时暴露于Ral的对照率百分比分别为43.48±3.90%和54.43±2.93%。单独暴露于MTX 24小时和36小时后的生长率分别为对照率的30.30±0.61%和33.11±2.27%。这些研究表明:(a)Ral与MTX之间的相互作用是顺序依赖性的;(b)当Ral给药先于MTX时,Ral拮抗MTX的作用;(c)Ral对MTX的拮抗作用是时间的函数。

相似文献

1
Sequence- and time-dependent antagonism between raloxifene and methotrexate in human breast cancer cells.雷洛昔芬与甲氨蝶呤在人乳腺癌细胞中的序列依赖性和时间依赖性拮抗作用。
Anticancer Res. 2002 Mar-Apr;22(2A):1007-9.
2
Raloxifene attenuation of 5-FU/methotrexate cytotoxicity in human breast cancer cells: the importance of sequence in combination chemotherapy.雷洛昔芬对人乳腺癌细胞中5-氟尿嘧啶/甲氨蝶呤细胞毒性的减弱作用:联合化疗中用药顺序的重要性
Anticancer Res. 2006 May-Jun;26(3A):1861-7.
3
Sequence-dependent antagonism between tamoxifen and methotrexate in human breast cancer cells.他莫昔芬与甲氨蝶呤在人乳腺癌细胞中的序列依赖性拮抗作用。
Anticancer Res. 2000 May-Jun;20(3A):1415-7.
4
Raloxifene attenuation of methotrexate cytotoxicity in human bone marrow by sequence-dependent administration of raloxifene, 5-FU/methotrexate.通过依序给予雷洛昔芬、5-氟尿嘧啶/甲氨蝶呤,雷洛昔芬减轻甲氨蝶呤对人骨髓的细胞毒性作用
Anticancer Res. 2006 May-Jun;26(3A):1877-83.
5
Raloxifene and selective cell cycle specific agents: a case for the inclusion of raloxifene in current breast cancer treatment therapies.雷洛昔芬与选择性细胞周期特异性药物:将雷洛昔芬纳入当前乳腺癌治疗方案的理由
Anticancer Res. 2007 May-Jun;27(3B):1393-9.
6
Implications for improved high-dose methotrexate therapeutic effects in cultured human breast cancer and bone marrow cells.高剂量甲氨蝶呤对培养的人乳腺癌细胞和骨髓细胞治疗效果的改善意义。
Cancer Detect Prev. 2000;24(5):452-8.
7
The interaction of the steroidal antagonist faslodex and methotrexate.甾体拮抗剂氟维司群与甲氨蝶呤的相互作用。
Cell Mol Biol (Noisy-le-grand). 2003 Nov;49(7):1067-9.
8
Sequential combination chemotherapy in human breast cancer: a basis for increased antineoplastic activity and bone marrow protection.人乳腺癌序贯联合化疗:增强抗肿瘤活性及保护骨髓的基础
Cell Mol Biol (Noisy-le-grand). 2007 May 15;53(3):18-26.
9
Sequence-dependent administration of raloxifene and 5-fluorouracil/pemetrexed protects against pemetrexed cytotoxicity in human bone marrow.雷洛昔芬与5-氟尿嘧啶/培美曲塞的序列依赖性给药可保护人骨髓免受培美曲塞的细胞毒性作用。
Anticancer Res. 2007 Mar-Apr;27(2):825-33.
10
Sequence-dependent administration of 5-fluorouracil maintains methotrexate antineoplastic activity in human estrogen-negative breast cancer and protects against methotrexate cytotoxicity in human bone marrow.5-氟尿嘧啶的序列依赖性给药可维持甲氨蝶呤在人雌激素阴性乳腺癌中的抗肿瘤活性,并保护人骨髓免受甲氨蝶呤的细胞毒性。
Anticancer Res. 2007 Nov-Dec;27(6B):3791-9.